AI Science Tracker

A new class of antibiotic candidates against MRSA

MIT · 20 Dec 2023 · medicine

Discovery

MIT

A new class of antibiotic candidates against MRSA

A deep-learning model trained on about 39,000 compounds screened about 12 million commercial compounds; of about 280 purchased and tested, two from the same class reduced MRSA burden tenfold in two mouse models, with very low toxicity to human cells. Results from plates and mice; toxicity was partly predicted computationally.

Technology: Deep learning with chemical-structure explainability

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: About 283 compounds were bought and tested empirically; one structural class reduced bacterial burden in mouse skin and systemic thigh infection models, and cytotoxicity to human cells was measured.
  • Still unknown: The page does not list specific study limitations; next steps are chemical property analysis and potential clinical use.
  • AI role: Graph neural network ensembles trained on about 39,000 compounds with measured antibacterial and human-cell toxicity predicted both properties for about 12 million compounds and flagged candidates for purchase and testing.

Evidence sources: https://news.mit.edu/2023/using-ai-mit-researchers-identify-antibiotic-candidates-1220 · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41586-023-06887-8&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 538 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.